An open label, comparative, sequential-dose, multi-centre study involving intracameral administration of a PA5108 Latanoprost FA SR Ocular Implant into the eye of patients with mild-moderate glaucoma

  • Graham, Stuart L. (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Rai, Meenal (Clinical Trial Unit Staff)

Project: Research

Project Details

Effective start/end date25/09/2031/05/25